Figure 2.
Computed tomography of the thorax with contrast before (A) and three months after the addition (B) of crizotinib to afatinib in October 2020. The mass (thick arrow) in the lingula responded to therapy. Incidental findings include subpleural consolidations (thin arrow) and dystelectasis (arrowheads) and slight interlobar effusion (*) on the right side.